Digital Art Therapy for Young Cancer Survivors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-25
SponsorUNC Lineberger Comprehensive Cancer Center

About this trial

This is a single-site, single-arm, interventional study assessing the feasibility of the ARTCan Therapy Application (App) and whether it is an acceptable means of administering art therapy to young adult cancer survivors. The ARTCan Therapy App guides participants through a 6-week digital art therapy program. Subjects will participate in weekly art therapy prompts guided by the app and will complete weekly mental health quality of life (MHQoL) surveys during the intervention. In addition, baseline and end-of-intervention patient-reported outcome measures (PROMIS-DSF8a) and an acceptability survey will be administered. The hypothesis is that digital art therapy is feasible for young adult cancer survivors with self-reported mood issues and is an acceptable means of administering art therapy in the patient population.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Written informed assent and parental consent obtained to participate in the study and HIPAA authorization for release of personal health information.

Subject is willing and able to comply with study procedures based on the judgment of the investigator.

Age 18-25 years at the time of consent.

Childhood cancer survivor, defined as having cancer between birth 17 years of age and who has completed cancer treatment.

Disqualifiers

All subjects meeting any of the exclusion criteria at baseline will be excluded from study participation.

Patients who lack interest in art. Screening question: Are you open to making art on a scale from 1-5 (1 being not at all, and 5 being very much; must score 3 or higher).

Subjects who lack basic technology skills (Screening question: On a scale of 1-5 (1 being uncomfortable, and 5 being very comfortable), how would you rate your comfort using websites. Must score 3 or higher).

Subjects unable to provide consent.

Trial design

Design model

Single group

Treatments tested in this trial

  • ARTCan App

    Behavioral

    The ARTCan App is an art therapy technology application program. The application can be accessed via the web (via computer, phone, or on a device such as an iPad). With the use of the application, participants complete weekly sessions that culminate in an "art" piece. Note that participants are not required to have expertise in drawing; developing art skills or assessing the quality of art pieces is not the focus of the ARTCan program. Subjects will upload a photo of the art they created to this application to show proof of completion of art therapy. They will also answer questions specific to the art therapy theme for the week.

Treatment groups

15 Participants
are divided into 1 treatment group
Group A: Digital Art TherapyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility of art therapy

The feasibility of art therapy will be determined by the proportion of participants who complete art therapy. The proportion of participants who complete 4 of the 6 art therapy modules will be determined. A completion rate of 10 out of 15 participants will be deemed feasible.

Time frame
Up to 6 weeks

Secondary outcomes

1

Acceptability of art therapy

Acceptability of art therapy will be measured as the proportion of participants responded to the survey questionnaire administered at the end of the intervention. The survey questionnaire will be taken via a web-based application as post- Intervention Assessment. Question: 1) Please provide your impression of the ARTCan App: A) I like the App B) I don't like the.

Time frame
at 6 week

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

UNC Lineberger Comprehensive Cancer Center

Lead sponsor

Ian's Friends Foundation

Collaborator